<![CDATA[VDYNE, Inc. 보도자료 - 뉴스와이어]]>https://www.newswire.co.kr/?md=A10&act=article&no=50485>Fri, 31 Jul 2026 03:34:29 +0900Copyright (c) 2004~2026 Korea Newswire All rights reservedko-KR<![CDATA[VDyne, TriNova™ 경카테터 삼첨판 치환 시스템의 TRIVITA 미국 IDE 중추 임상시험에서 첫 환자 치료 발표]]>https://www.newswire.co.kr/newsRead.php?no=1039666Thu, 30 Jul 2026 15:40:00 +0900<![CDATA[VDyne Announces First Patient Treated in TRIVITA US IDE Pivotal Study of the TriNova™ Transcatheter Tricuspid Valve Replacement System]]>https://www.newswire.co.kr/newsRead.php?no=1039668Thu, 30 Jul 2026 15:40:00 +0900<![CDATA[VDYNE Receives FDA Approval to Initiate the TRIVITA[1] IDE Pivotal Trial of Transcatheter Tricuspid Valve Replacement System]]>https://www.newswire.co.kr/newsRead.php?no=1031711Fri, 03 Apr 2026 13:30:00 +0900<![CDATA[브이다인, 경도자 삼첨판 치환술 시스템의 ‘트리비타[1]’ IDE 확증 임상시험 개시에 대한 FDA 승인 획득]]>https://www.newswire.co.kr/newsRead.php?no=1031712Fri, 03 Apr 2026 13:30:00 +0900